HC
ELOS

Hourglass Capital’s Syneron Medical Ltd ELOS Stock Holding History

Hourglass Capital’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-709,666
Closed -$5.07M – 114
2015
Q3 		$5.07M Sell
709,666
-8,777
-1% -$84.3K 1.11% 41
2015
Q2 		$7.63M Sell
718,443
-42,971
-6% -$503K 1.2% 22
2015
Q1 		$9.43M Sell
761,414
-154,027
-17% -$1.71M 1.41% 16
2014
Q4 		$8.54M Sell
915,441
-38,607
-4% -$372K 1.54% 14
2014
Q3 		$9.56M Hold
954,048
– – 1.27% 15
2014
Q2 		$9.85M Buy
954,048
+272,620
+40% +$2.95M 1.43% 17
2014
Q1 		$8.48M Sell
681,428
-157,472
-19% -$1.87M 1.41% 23
2013
Q4 		$10.3M Hold
838,900
– – 1.65% 19
2013
Q3 		$7.23M Hold
838,900
– – 1.26% 28
2013
Q2 		$7.3M Buy
+838,900
New +$7.5M 1.34% 20

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hourglass Capital's ELOS Position: Q4 2015 in Review

Hourglass Capital sold out of Syneron Medical Ltd (ELOS) in Q4 2015, closing a stake of 709,666 shares — an estimated $5.07M sold.

Hourglass Capital first reported a position in ELOS in Q2 2013 and held it in 10 quarters. The position peaked at $10.3M in Q4 2013. 57 funds tracked by Wall St. Rank hold ELOS as of Q4 2015.

  • Hourglass Capital reported no remaining Syneron Medical Ltd position as of Q4 2015 after selling out during the quarter.
  • Hourglass Capital sold 709,666 Syneron Medical Ltd shares in Q4 2015, an estimated $5.07M.
  • Hourglass Capital first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 10 quarters.
  • Hourglass Capital's Syneron Medical Ltd position peaked at $10.3M in Q4 2013.
  • 57 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2015.

Based on Hourglass Capital's 13F filing for Q4 2015, filed 9 Feb 2016.